US-CONGRESS S3794: SAFE Drugs Act of 2026
The SAFE Drugs Act of 2026 has been placed on the Senate Legislative Calendar, advancing toward potential passage. This bill would impose new cGMP requirements, modify DEA quotas for controlled substances, and enhance DSCSA track-and-trace provisions, affecting drug manufacturers, API suppliers, and compounders.
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on July 28, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Branded drug makers, generic/ANDA manufacturers, API & contract manufacturers, compounding outsourcing (503B) facilities should confirm how it applies to their specific situation before acting. There is a time constraint attached: The bill is on the calendar; passage could occur within weeks. Immediate action recommended.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The bill introduces stricter cGMP standards, new DEA quota adjustments for controlled substances, and expanded DSCSA serialization requirements. It also includes provisions to address drug shortages and antidumping measures.
Who it affects
Branded drug makers, generic/ANDA manufacturers, API & contract manufacturers, compounding outsourcing (503B) facilities
What you must do
Review current cGMP compliance programs, assess DEA quota allocations, and evaluate DSCSA serialization readiness. Begin lobbying or preparing for compliance if the bill passes.
Deadline
The bill is on the calendar; passage could occur within weeks. Immediate action recommended.
Source: https://www.congress.gov/bill/119th-congress/senate-bill/3794
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trial